BSECompany Update6 Aug 2026 · 6 Aug 2026, 06:04 pm
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, ....
Colinz Laboratories Ltd · 531210
✦ AI SummaryFundraise
Colinz Laboratories Ltd has received an open offer from Saffron Capital Advisors Pvt Ltd on behalf of Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 6,54,966 shares, representing 26% of the company's voting share capital, at ₹54 per share.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Colinz Laboratories Ltd - 531210 - Updates on Open Offer
Attachments (1)
📄pdf
Download →
834E448D-C819-49F7-AF3A-67878FCCD4F9-180407.pdf
View document text
Saffron Capital Advisors Private Limited
304, A Wing, 215 Atrium,
M V Road, Chakala,
Andheri East, Mumbai-400093
Tel.: +91-22-49730394
Email: info@saffronadvisor.com
Website: www.saffronadvisor.com
CIN No.: U67120MH2007PTC166711
August 06, 2026
Listing Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai – 400 001
Scrip Code: 531210
Dear Sir/Madam,
Sub: Open Offer by Annjana Dugar (“Acquirer 1”), Likhitta Dugar (“Acquirer 2”) and Antariksh Dugar
(“Acquirer 3”) (Hereinafter Acquirer 1, Acquirer 2 and Acquirer 3 collectively referred to as "Acquirers")
Together with Padam Dugar (“Person Acting In Concert” or “PAC”), to acquire up to 6,54,966 (Six Lakh Fifty
Four Thousand Nine Hundred and Sixty Six) fully paid-up Equity Shares of face value of ₹ 10/- (Rupees Ten
only) each for cash at a price of ₹ 54/- (Rupees Fifty Four only) per Equity Shares aggregating up to ₹
3,53,68,164/- (Rupees Three Crore Fifty Three Lakh Sixty Eight Thousand One Hundred Sixty Four Only),
representing 26% (Twenty Six Percent) of the Voting Share Capital of the Target Company, to the Public
Shareholders of Colinz Laboratories Limited (“Target Company”) pursuant to and in compliance with the
requirements of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011, as amended (“SEBI (SAST) Regulations, 2011”) (“Offer” Or “Open Offer”).
We have been appointed as ‘Manager’ to the captioned Open Offer by the Acquirers and the PAC in terms of regulation
12(1) of the SEBI (SAST) Regulations. In this regard, we are enclosing the following for your kind reference and
records:
A copy of offer opening public announcement and corrigendum to the Detailed Public Statement (“Offer Opening
Public Announcement and Corrigendum”) dated August 05, 2026. The offer opening public announcement was
published today, August 06, 2026 in the following newspapers:-
Sr. Newspapers Language Editions
1 Financial Express English All Editions
2 Jansatta Hindi All Editions
3 Pratahkal Marathi Mumbai Edition - Place of Stock Exchange at which
shares of the Target Company are listed and Place
where registered office of the Target Company is
situated
In case of any clarification required, please contact the person as mentioned below:
Contact Person Designation Contact Number E-mail Id
Saurabh Senior Manager and Assistant saurabh@saffronadvisor.com
Gaikwad Compliance Officer +91 22 49730394
Shivam Sharma Assistant Manager shivam@saffronadvisor.com
Registered Office: 605, Sixth Floor, Centre Point, J B Nagar, Andheri East, Mumbai-400059/ SEBI Registration No: INM000011211
Continuation Sheet
We request you to kindly consider the attachments as good compliance and disseminate it on your website.
For Saffron Capital Advisors Private Limited
Saurabh Gaikwad
Senior Manager and Assistant Compliance Officer
Equity Capital Markets
Encl: a/a
CIN No.: U67120MH2007PTC166711 SEBI Registration No: INM000011211 Website: www.saffronadvisor.com Email: info@saffronadvisor.com
www. pratahkal.com